Mereo BioPharma Files 8-K on Shareholder Votes & Financials
Ticker: MREO · Form: 8-K · Filed: May 23, 2024 · CIK: 1719714
| Field | Detail |
|---|---|
| Company | Mereo Biopharma Group PLC (MREO) |
| Form Type | 8-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-actions, financials
TL;DR
Mereo BioPharma filed an 8-K for shareholder votes and financials. London HQ confirmed.
AI Summary
Mereo BioPharma Group plc filed an 8-K on May 23, 2024, to report on matters submitted to a vote of security holders and financial statements. The filing details the company's principal executive offices located at 4th Floor, One Cavendish Place, London, W1G 0QF, United Kingdom.
Why It Matters
This filing provides an update on important corporate actions and financial reporting for Mereo BioPharma, which can influence investor decisions.
Risk Assessment
Risk Level: low — This is a routine SEC filing reporting on corporate actions and financial statements, not indicating new material risks.
Key Players & Entities
- Mereo BioPharma Group plc (company) — Registrant
- May 23, 2024 (date) — Date of earliest event reported
- 4th Floor, One Cavendish Place, London, W1G 0QF United Kingdom (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on matters submitted to a vote of security holders and to provide financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 23, 2024.
Where are Mereo BioPharma Group plc's principal executive offices located?
Mereo BioPharma Group plc's principal executive offices are located at 4th Floor, One Cavendish Place, London, W1G 0QF, United Kingdom.
What is the company's SEC file number?
The SEC file number for Mereo BioPharma Group plc is 001-38452.
What is the Standard Industrial Classification code for Mereo BioPharma Group plc?
The Standard Industrial Classification code for Mereo BioPharma Group plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 827 words · 3 min read · ~3 pages · Grade level 9.6 · Accepted 2024-05-23 16:16:05
Filing Documents
- d840193d8k.htm (8-K) — 48KB
- 0001193125-24-145983.txt ( ) — 215KB
- mreo-20240523.xsd (EX-101.SCH) — 3KB
- mreo-20240523_def.xml (EX-101.DEF) — 15KB
- mreo-20240523_lab.xml (EX-101.LAB) — 24KB
- mreo-20240523_pre.xml (EX-101.PRE) — 16KB
- d840193d8k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 23, 2024 MEREO BIOPHARMA GROUP PLC By: /s/ Charles Sermon Name: Charles Sermon Title: General Counsel